Kodama, Fumio <br/><br/>
[Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events].  [electronic resource] 

 -  Gan to kagaku ryoho. Cancer & chemotherapy  Feb 2002 
 - 273-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>0385-0684 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antiemetics--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bleomycin--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Leucovorin--administration & dosage<br/>Lymphoma--drug therapy<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Nausea--chemically induced<br/>Ondansetron--therapeutic use<br/>Prednisolone--administration & dosage<br/>Prednisone--administration & dosage<br/>Prognosis<br/>Vincristine--administration & dosage<br/>Vomiting, Anticipatory--drug therapy